Palliative Care MPhil/PhD/MD

Major code: PVPR/PVMR/PVMD


The Department of Molecular and Clinical Cancer Medicine forms the mainstay of the new NWCR Centre – University of Liverpool.

Subject Overview

The University has invested over £20million in cancer research which has been used for the creation of several new posts in the Department, and in the establishment of the University of Liverpool Cancer Research Centre (ULCRC) building. This commitment to cancer research has resulted in the launch of Liverpool Cancer Research UK Centre – an organisation thatbrings together scientists, clinicians and local stakeholders to lead and deliver cancer research of the highest quality and importance.

Research income itself now exceeds £25m and includes funding from Cancer Research UK, Leukaemia and Lymphoma Research, Northwest Cancer Research Fund, Kay Kendal Leukaemia Fund, Wellcome Trust, MRC, NIHR, BBSRC and a number of industrial partners. The Department also enjoys participation within the European Funding Networks.

Key Facts

The Institute of Translational Medicine comprises six departments:
Cellular and Molecular Physiology
Molecular and Clinical Pharmacology
Molecular and Clinical Cancer Medicine
Women’s and Children’s Health

The work of the Institute:
Takes place in the laboratory and in the clinic, forming a continuous cycle of scientific discovery and clinical research that’s yielding remarkable advances in healthcare provision.

A primary aim:
Is to provide the necessary infrastructure, facilities, professional support and environment to foster collaborative research between basic science and clinical science postgraduates.

The Institute draws on:
The established expertise within each Department to foster, develop and enhance translational medicine work streams and projects throughout the Institute as a whole.

Why The Department of Molecular and Clinical Cancer Medicine ?

Broad range of research themes

The principal research themes in the Department ( include basic cancer cell and molecular biology, translational research and tumour specific research in many areas including pancreatic, head and neck cancer, urological, breast, gastro-oesophageal, colorectal, gynaecological and lung cancers as well as paediatric cancers and haemato-oncology.

Research strengths

The Research Assessment Exercise 2008 identified particular strengths within the Department including basic research in cytokinesis and DNA damage response, the molecular and cellular biology of lymphoid and myeloid leukaemias and the genetics of squamous cell carcinoma.

Strong allegiances

The Department is closely aligned with North West Cancer Research Centre - University of Liverpool (, the Cancer Research UK Liverpool Cancer Trials Unit, the Cancer Research UK/NIHR Liverpool Experimental Cancer Medicine Centre ( and the NIHR Pancreas Biomedical Research Unit. In addition, the Department of Molecular and Clinical Cancer Medicine is home to the Marie Curie Palliative Care Institute.